First Trust Nasdaq Lux Digital Health Solutions ETF
EKG
NASDAQ Global Market- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management - Global
- Address
- 120 East Liberty Drive, Suite 400 Wheaton IL United States of America 60187
- IPO Date
- Mar 23, 2022
- CIK
- 0001364608
- Website
- ftportfolios.com
- Similar Companies
- Business
- First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) is an exchange-traded fund that seeks investment results corresponding generally to the price and yield, before fees and expenses, of the Nasdaq Lux Health Tech Index. The fund normally invests at least 80% of its net assets in common stocks and depositary receipts comprising the index, which measures the performance of companies primarily engaged in digital health solutions at the intersection of healthcare and technology; these include providers of health care technology platforms and services, medical equipment and devices, pharmaceuticals and biotechnology, and related software and computer services. Top holdings as of late 2025 feature IQVIA Holdings Inc. (8.74%), Veeva Systems Inc. (8.22%), Intuitive Surgical Inc. (7.46%), ResMed Inc. (7.46%), and DexCom Inc. (7.06%), with the portfolio spanning approximately 38 securities concentrated in the healthcare sector (99.84%), predominantly U.S.-based (99.27%). Launched on March 22, 2022, and domiciled in the United States, the ETF is managed by First Trust Advisors LP, with key portfolio managers including Roger Testin, Daniel Lindquist, Jon Erickson, David McGarel, Stan Ueland, Chris Peterson, Erik Russo, and others who assumed roles at inception. The fund maintains a net expense ratio of 0.65% and total net assets of approximately $2.9 million as of recent data, trading on Nasdaq with a focus on mid-cap growth-style investments in the health category. Recent developments include routine quarterly rebalancing of the underlying index to reflect evolving digital health innovations, alongside minor portfolio adjustments such as the addition or weighting shifts for emerging holdings like Hims & Hers Health Inc., Natera Inc., and Exact Sciences Corp. in 2025; the fund has also seen board and audit committee appointments at the First Trust level in March 2024, enhancing governance oversight. No major acquisitions, funding rounds, or strategic alliances specific to EKG have been reported in the last 1-2 years, though the ETF continues to track sector growth amid ongoing technological progress in healthcare.